Select for export A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-08-18 COMPASS Pathways ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionPharmacologyClinical Trial Clinical Trial More
Select for export Attitudes Toward Psychedelic-Assisted Therapies for Cancer-Related Psychosocial Symptoms: A Multi- Stakeholder Analysis Abstract available at the source but not redistributed here. Read at source. Details DOI 10.21203/rs.3.rs-6941009/v1 Copy citation Copy BibTeX Research Square 2025-08-18 Schuman HD, Deleemans JM, Nguyen T, Savard C, Mina R, Carlson LE. Europe PMC PREPRINT (not peer reviewed) psilocybin End-of-Life DistressObservational StudyCancer Patients Observational Study More
Select for export Serotonin and psilocybin activate 5-HT1B receptors to suppress cortical signaling through the claustrum Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41467-025-62980-8 PubMed 40830107 Copy citation Copy BibTeX Nature Communications 2025-08-18 Maxwell B. Madden, Chloe Schaefgen, Binita Vedak, Jian Kwon, Kiara S. Dresp Pedra, Samuel H. Sheats OpenAlex Published psilocybinpsilocin NeuroplasticityPharmacologyMechanism of Action Other More
Select for export Exploring the therapeutic potential of psychedelics in treating substance use disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41380-025-03168-w PubMed 40830580 Copy citation Copy BibTeX Unknown journal 2025-08-18 Li Y, Li H, Wang H, Wang X. Europe PMC Published psilocybin AddictionNeuroplasticityClinical Trial Clinical Trial More
Select for export Psychedelic-assisted therapies for existential and spiritual suffering in palliative care. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/bs.pbr.2025.07.002 PubMed 40967680 Copy citation Copy BibTeX Unknown journal 2025-08-17 Garcia ACM, Maia LO. Europe PMC Published psilocybin End-of-Life DistressMechanism of ActionSpirituality Review Article More
Select for export Exploring the Therapeutic Potential of Ketamine and Psilocybin in Comparison to Current Treatment Regimens for Treatment-Resistant Depression, Mood Disorders, and Post-traumatic Stress Disorder in the Pediatric Population: A Narrative Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7759/cureus.90425 PubMed 40970030 Copy citation Copy BibTeX Unknown journal 2025-08-17 Hughes B, Mirza S, Ponamala M, Sagaser J, Paredes R, Hematillake N Europe PMC Published psilocybin DepressionAnxietyPTSD Meta-Analysis More
Select for export Psilocybin treatment for symptoms of depression: a living systematic review, meta-analysis, and data resource Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2025.08.13.25333530 Copy citation Copy BibTeX medRxiv 2025-08-15 Singleton SP, Sevchik BL, Lahey A, Cuijpers P, Harrer M, Jones MT medRxiv PREPRINT (not peer reviewed) psilocybin DepressionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export Therapeutic Divergence in 5-HT2A Agonism: Psilocybin and Phenalkylamines for Demoralization Syndrome. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acsmedchemlett.5c00475 PubMed 40959252 Copy citation Copy BibTeX Unknown journal 2025-08-14 Kargbo RB. Europe PMC Published psilocybin DepressionReceptor PharmacologySafety Other More
Select for export Endocannabinoids, depression, and treatment resistance: Perspectives on effective therapeutic interventions. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.psychres.2025.116697 PubMed 40840197 Copy citation Copy BibTeX Unknown journal 2025-08-14 Rosa I, Padula LP, Semeraro F, Marrangone C, Inserra A, De Risio L Europe PMC Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Review Article More
Select for export Perspectives on Trauma Treatment, Self-Management Strategies, and Attitudes Toward Psychedelic Therapies in Individuals with Psychological Trauma Symptoms Abstract available at the source but not redistributed here. Read at source. Details DOI 10.5152/pcp.2025.24934 PubMed 40864832 Copy citation Copy BibTeX Psychiatry and Clinical Psychopharmacology 2025-08-13 Nadav Liam Modlin, Jessica L. Maples-Keller, Maria Sarang, Lucie Siebenaler, Carolina Maggio, Susannah Pick OpenAlex Published psilocybin PTSDReceptor PharmacologyClinical Trial Clinical Trial More
Select for export Toward Standardized Products Containing Biomass of Psilocybe Cubensis Fungi Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/jaoacint/qsaf072 PubMed 40802522 Copy citation Copy BibTeX Journal of AOAC International 2025-08-12 Kimberley Foster, Isaac Morrison, Shemar Daniel, Johann M.R. Antoine, Babumon M. Thankappan, Winston De La Haye OpenAlex Published psilocybinpsilocin WellbeingClinical TrialHealthcare Workers Clinical Trial More
Select for export Hallucinogen-Persisting Perception Disorder in a 16-Year-Old Adolescent Abstract available at the source but not redistributed here. Read at source. Details DOI 10.64719/pb.4525 PubMed 39935673 Copy citation Copy BibTeX Psychopharmacology Bulletin 2025-08-11 Anna Mori-Kreiner, Arpit Aggarwal, Meelie Bordoloi OpenAlex Published psilocybin DepressionAddictionReview Article Review Article More
Select for export Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.genhosppsych.2025.08.001 PubMed 40858059 Copy citation Copy BibTeX General Hospital Psychiatry 2025-08-11 Margaret Ross, Ravi Iyer, M.L. Williams, Mark Boughey, Clare O’Callaghan, Richard Hiscock OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Randomized Controlled Trial More
Select for export Psychedelic researchers’ own experiences of psychedelic substances, their link to opinions of psychedelics, and reflections on positionality Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-025-06871-2 PubMed 40788485 Copy citation Copy BibTeX Psychopharmacology 2025-08-10 Jussi Jylkkä, Aila Mustamo OpenAlex Published psilocybin WellbeingSpiritualityToxicity Other More
Select for export Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.12659/msm.948302 PubMed 40781763 Copy citation Copy BibTeX Unknown journal 2025-08-08 Silczuk A, Madejek RJ, Koweszko T, Mularczyk-Tomczewska P, Adamska E, Gujski M Europe PMC Published psilocybin DepressionPTSDAddiction Clinical Trial More
Select for export Psychedelics and Headache Disorders: an Update. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s11910-025-01446-2 PubMed 40782223 Copy citation Copy BibTeX Current neurology and neuroscience reports 2025-08-08 Im JJH, Sandoe CH PubMed Published psilocybin Chronic PainHeadache / MigraineReview Article Review Article More
Select for export Intersecting Psychedelic Pharmacology and Gut-Brain Axis Signaling in Neurodegenerative Disorders Abstract available at the source but not redistributed here. Read at source. Details DOI 10.52340/jr.2025.03.03.09 Copy citation Copy BibTeX JUNIOR RESEARCHERS 2025-08-07 Harsha S. Krishna OpenAlex Published psilocybin NeuroplasticityPharmacologyMechanism of Action Clinical Trial More
Select for export The psychedelic renaissance: psilocybin, a breakthrough for treatment resistant depression? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.37349/en.2025.1006105 Copy citation Copy BibTeX Exploration of neuroscience 2025-08-06 Trevor R. Norman OpenAlex Published psilocybin DepressionHeadache / MigraineEmotional Processing Other More
Select for export Substance Abuse and Cognitive Decline: The Critical Role of Tau Protein as a Potential Biomarker. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/ijms26157638 PubMed 40806766 Copy citation Copy BibTeX Unknown journal 2025-08-06 Rebolledo-Pérez L, Hernández-Bello J, Martínez-Ramos A, Castañeda-Arellano R, Fernández-Quezada D, Sandoval-García F Europe PMC Published psilocybin AddictionNeuroplasticityMechanism of Action Review Article More
Select for export Psilocybin triggers an activity-dependent rewiring of large-scale cortical networks Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2025.08.06.668927 Copy citation Copy BibTeX bioRxiv 2025-08-05 Jiang Q, Shao L, Yao S, Savalia NK, Gilbert AD, Davoudian PA bioRxiv PREPRINT (not peer reviewed) psilocybin NeuroplasticityDefault Mode NetworkAnimal Study Animal Study More
